We will discuss the deleterious cardiovascular effects of anthracyclines and HER2-targeted agents in a case-based format, as well as specific approaches to prevention and treatment of associated cardiotoxicity.
Richard M. Steingart, MD
Advertisement
Articles by Richard M. Steingart, MD
Advertisement
Latest Updated Articles
- Chemotherapy-Induced Cardiomyopathy: Clinical Scenarios and Challenges
Published: October 15th 2015 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Belzutifan Plus Lenvatinib Improves PFS/ORR in Advanced Pretreated RCC
2
JSKN003 Receives FDA Fast Track Designation in Advanced PROC
3
Response Rates Show Promise in Phase 1 trial Involving ASCT in Metastatic PDAC
4
What Path to Approval Has Dasatinib Taken in CML/ALL?
5
